Company: HURA
Filing Date: 2025-09-18
Form Type: S-1/A
Source: 0001193125-25-207395
Chunk: 227

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-09-18
Form: S-1/A
Chunk 227
---
berg disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein. |

| (12) | Excludes, for beneficial ownership purposes, 37,736 warrants to purchase common stock purchased in the Offering that are not exercisable until December 3, 2025. |

| (13) | Excludes, for beneficial ownership purposes, 94,340 warrants to purchase common stock purchased in the Offering that are not exercisable until December 3, 2025. |

| (14) | The reported securities are held directly by Norton Capital LLC (“Norton Capital”), and may be deemed to be beneficially owned by Robert Norton, as the Manager of Norton Capital. Robert Norton disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |

| (15) | Excludes, for beneficial ownership purposes, 37,736 warrants to purchase common stock purchased in the Offering that are not exercisable until December 3, 2025. |

| (16) | The reported securities are held directly by RAJK Family Limited Partners LLC (“RAJK”), and may be deemed to be beneficially owned by Amita Patel, as the Manager of RAJK. Amita Patel disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein. |

| (17) | Excludes, for beneficial ownership purposes, 150,944 warrants to purchase common stock purchased in the Offering that are not exercisable until December 3, 2025. |

| (18) | The reported securities are held directly by Tapper Ventures Inc. and may be deemed to be beneficially owned by Thomas Pepin, who has sole voting and investment power. Thomas Pepin disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |

| (19) | Excludes, for beneficial ownership purposes 188,680 warrants to purchase common stock purchased in the Offering that are not exercisable until December 3, 2025. |

| (20) | Excludes, for beneficial ownership purposes, 37,736 warrants to purchase common stock purchased in the Offering that are not exercisable until December 3, 2025. |

| (21) | Excludes, for beneficial ownership purposes, 226,416 warrants to purchase common stock purchased in the Offering that are not exercisable until December 3, 2025. |

148

| (22) | The reported securities are held directly by K